NYSE:BHC Bausch Health Cos Q3 2026 Earnings Report $5.80 +0.08 (+1.31%) Closing price 10/2/2026 03:59 PM EasternExtended Trading$5.80 0.00 (-0.07%) As of 10/2/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Bausch Health Cos EPS ResultsActual EPSN/AConsensus EPS $1.24Beat/MissN/AOne Year Ago EPSN/ABausch Health Cos Revenue ResultsActual RevenueN/AExpected Revenue$2.70 billionBeat/MissN/AYoY Revenue GrowthN/ABausch Health Cos Announcement DetailsQuarterQ3 2026Date10/28/2026TimeAfter Market ClosesConference Call DateWednesday, October 28, 2026Conference Call Time5:00PM ETConference Call ResourcesEarnings HistoryCompany Profile Bausch Health Cos Earnings HeadlinesQ3 EPS Estimate for Bausch Health Cos Raised by AnalystOctober 4 at 1:28 AM | americanbankingnews.comImmuCell (NASDAQ:ICCC) versus Bausch Health Cos (NYSE:BHC) Head to Head SurveySeptember 28, 2026 | americanbankingnews.comYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.October 4 at 1:00 AM | Profits Run (Ad)Zacks Research Analysts Increase Earnings Estimates for BHCSeptember 25, 2026 | americanbankingnews.comBausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA MarketsSeptember 8, 2026 | prnewswire.comBausch Health Companies Inc. (BHC)August 28, 2026 | finance.yahoo.comSee More Bausch Health Cos Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bausch Health Cos? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bausch Health Cos and other key companies, straight to your email. Email Address About Bausch Health CosBausch Health Companies Inc. is a multinational specialty pharmaceutical company headquartered in Laval, Quebec. The company develops, manufactures and markets prescription medicines, branded and generic pharmaceuticals, over-the-counter products and medical devices across a range of therapeutic areas. Its business includes Salix Pharmaceuticals, which focuses on gastrointestinal treatments; Ortho Dermatologics, which develops prescription therapies for dermatological conditions; and Solta Medical, which provides energy-based medical and aesthetic devices. Bausch Health also markets pharmaceutical products internationally through its diversified portfolio. The company operates in North America, Europe, Latin America and other international markets. Bausch Health was formerly known as Valeant Pharmaceuticals International and adopted its current name in 2018. Thomas J. Appio serves as the company’s chief executive officer.View Bausch Health Cos ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/28 - 10/02Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?Time to Nibble on MCD Stock After it Enters Oversold Territory?Liberty Energy’s AI Power Push Has Wall Street DividedMcCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the Test Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
